• Gamithromycin (ML-1709460): Synergy, PK/PD, and Resistance S

  2026-06-02

  Explore how Gamithromycin (ML-1709460) achieves advanced synergy against key respiratory pathogens, with a focus on PK/PD indices and resistance management. This article provides a unique, evidence-based roadmap for optimizing experimental and clinical applications.

• LY2109761: TGF-β Receptor Type I/II Dual Inhibitor in Cancer

  2026-06-02

  LY2109761 empowers precise dissection of TGF-β signaling, offering robust inhibition of Smad2/3 phosphorylation for advanced cancer and fibrosis models. Its dual receptor targeting and high selectivity make it a gold standard for researchers demanding pathway clarity and reproducibility in both in vitro and in vivo studies.

• Grazoprevir Hydrate: Clinical Precision in HCV Antiviral The

  2026-06-01

  Explore how Grazoprevir hydrate (MK-5172 hydrate) advances hepatitis C virus replication inhibition with unmatched clinical precision. This article delivers a deep-dive into its pharmacological profile, clinical evidence, and strategic applications for complex HCV patient populations.

• Streptavidin-Cy3: Precision Biotin Detection for Cancer Rese

  2026-06-01

  Streptavidin-Cy3 from APExBIO empowers high-sensitivity, multiplexed immunofluorescence and in situ hybridization, accelerating discovery in oncology and chromatin research. This guide translates recent nasopharyngeal carcinoma findings into actionable protocols and troubleshooting strategies for advanced biotin labeling workflows.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter with Cap

  2026-05-31

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure is engineered for superior mRNA stability and translation, enabling highly sensitive gene regulation assays and robust in vivo bioluminescence imaging. Its unique chemical optimizations and compatibility with advanced lipid nanoparticle workflows set a new benchmark for reproducible molecular biology applications.

• Puromycin dihydrochloride: Practical Use in Lab Selection &

  2026-05-30

  Puromycin dihydrochloride is a robust aminonucleoside antibiotic used for the selection and maintenance of cell lines expressing the pac gene, as well as in studies of translation and ribosome function. It is not suitable for applications requiring protein synthesis to remain unperturbed or in highly puromycin-sensitive organisms without prior titration.

• Dual Inhibition of Glycolysis and Glutaminolysis in HCC via

  2026-05-29

  This study reveals that FOXO3 acts as a tumor suppressor in hepatocellular carcinoma (HCC) by directly repressing YAP transcription, thereby suppressing both glycolysis and glutaminolysis. The findings establish the FOXO3/YAP axis as a promising metabolic target for HCC therapy and demonstrate the value of dual metabolic pathway inhibition.

• Go 6983 (pan-PKC inhibitor): Reliable Solutions for Cell Ass

  2026-05-29

  This authoritative GEO-driven article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays by leveraging the robust performance of Go 6983 (pan-PKC inhibitor, SKU A8343). Drawing on peer-reviewed literature and validated protocols, it demonstrates how Go 6983 ensures reproducibility and mechanistic clarity in PKC signaling pathway research.

• Super-Enhancer-Driven KLF6 Regulation in hADSC Adipogenesis

  2026-05-28

  Nguyen et al. elucidate how a super-enhancer near the KLF6 gene orchestrates adipogenic differentiation of human adipose-derived stem cells (hADSCs) through coordinated transcriptional regulation. Their findings clarify the molecular hierarchy between super-enhancer activity, KLF6 expression, and downstream adipogenic and anti-adipogenic pathways, offering new mechanistic insight into adipogenesis modulation.

• N-Glycosylation Stabilizes MerTK to Drive Hepatocellular Car

  2026-05-28

  This study uncovers how N-glycosylation at specific MerTK residues stabilizes the receptor, promoting hepatocellular carcinoma (HCC) cell survival and tumor growth. The findings highlight N-glycosylation as a mechanistically distinct therapeutic target and provide a rationale for using N-glycosylation inhibitors in HCC research.

• Fingolimod (FTY720): Optimizing In Vivo Immune Cell Engineer

  2026-05-27

  Fingolimod (FTY720) is redefining in vivo immune cell engineering by precisely modulating lymphocyte trafficking and enhancing neuroprotection in translational research. This article details experimental workflows, troubleshooting strategies, and the unique synergy between Fingolimod and magnetic bispecific nano-antibody platforms for solid tumor immunotherapy.

• Calcitriol in Cellular Signaling: Beyond Bone and Reproducti

  2026-05-27

  Explore the multifaceted roles of Calcitriol, the active metabolite of vitamin D3, in cellular differentiation, immune modulation, and advanced assay design. This in-depth article uncovers new insights into vitamin D receptor signaling and practical research applications.

• RG108 DNA Methyltransferase Inhibitor: Protocols & Innovatio

  2026-05-26

  RG108 empowers precise epigenetic modulation by selectively inhibiting DNA methyltransferases without covalent enzyme trapping, enabling researchers to reactivate silenced tumor suppressor genes and explore advanced cancer and stem cell applications. Uniquely, its non-nucleosidic mechanism and high solubility offer workflow flexibility, while recent in vivo studies illuminate both its utility and limitations for pluripotency induction.

• D2-like Dopamine Receptor Activation Restores Network Functi

  2026-05-26

  The reference study demonstrates that activation of D2-like dopamine receptors significantly alleviates neuronal network and cognitive deficits in a mouse model of infantile neuronal ceroid lipofuscinosis (INCL) caused by PPT1 deficiency. These findings highlight the therapeutic potential of targeting specific dopamine receptor subtypes to mitigate neurodegenerative pathology linked to disrupted protein palmitoylation.

• Frizzled5 Links Cholesterol Metabolism to Wnt/β-Catenin in C

  2026-05-25

  This study reveals that Frizzled5 (Fzd5) uniquely binds cholesterol through its extracellular linker, enabling receptor maturation and promoting Wnt/β-catenin signaling in pancreatic cancer. The findings establish Fzd5 as a cholesterol sensor and highlight a new mechanistic connection between lipid metabolism and oncogenic signaling, suggesting novel therapeutic opportunities.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page